Vancomycin and Nph insulin drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Vancomycin (vancomycin) and Nph insulin (insulin susp isophane beef). Common drug interactions include cardiac failure congestive among females and cutaneous vasculitis among males.

The phase IV clinical study analyzes what interactions people have when they take Vancomycin and Nph insulin. It is created by eHealthMe based on reports of 17 people who take the same drugs from the FDA, and is updated regularly.

What is Vancomycin?

Vancomycin has active ingredients of vancomycin. eHealthMe is studying from 17,165 Vancomycin users. Check the latest studies of Vancomycin.

What is Nph insulin?

Nph insulin has active ingredients of insulin susp isophane beef. It is often used in diabetes. eHealthMe is studying from 1,871 Nph insulin users. Check the latest studies of Nph insulin.



On Jul, 04, 2026

17 people who take Vancomycin and Nph insulin together, and have interactions are studied.

Vancomycin and Nph insulin drug interactions.

What are the common drug interactions of Vancomycin and Nph Insulin, by gender? *:

female:

  1. Cardiac failure congestive
  2. Cerebrovascular accident (sudden death of some brain cells due to lack of oxygen when the blood flow to the brain is impaired by blockage or rupture)
  3. Chronic kidney disease
  4. Pneumonia bacterial (pneumonia associated with bacterial infection)
  5. Pulmonary sepsis (pus in lungs)
  6. Sepsis (a severe blood infection that can lead to organ failure and death)
  7. Drug ineffective
  8. Acute respiratory failure
  9. Acute left ventricular failure (heart attack)
  10. Bronchitis (inflammation of the mucous membrane in the bronchial tubes)

male:

  1. Cutaneous vasculitis (an inflammatory process affecting the vessel wall that leads to its damage)
  2. Tumour lysis syndrome (a group of metabolic complications that can occur after treatment of cancer, these complications are caused by the breakdown products of dying cancer cells)
  3. Gingival bleeding (bleeding gums)
  4. Haematoma (collection of blood outside the blood vessels)
  5. Haemorrhage intracranial (bleeding within the skull)
  6. Hypernatraemia (an abnormally high plasma concentration of sodium ions)
  7. Hypertension (high blood pressure)
  8. Leukocytosis (increased white blood cells)
  9. Liver injury
  10. Metabolic acidosis (body produces too much acid, or when the kidneys are not removing enough acid from the body)

What are the common drug interactions of Vancomycin and Nph Insulin, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

  1. Tumour lysis syndrome (a group of metabolic complications that can occur after treatment of cancer, these complications are caused by the breakdown products of dying cancer cells)

20-29:

n/a

30-39:

  1. Drug ineffective

40-49:

  1. Abdominal pain
  2. Large intestine perforation (hole in large intestine)

50-59:

  1. Cutaneous vasculitis (an inflammatory process affecting the vessel wall that leads to its damage)
  2. Acute respiratory failure
  3. Death
  4. Thrombocytopenia (decrease of platelets in blood)

60+:

  1. Cardiac failure congestive
  2. Pneumonia bacterial (pneumonia associated with bacterial infection)
  3. Bronchitis (inflammation of the mucous membrane in the bronchial tubes)
  4. Cardio-respiratory arrest (sudden dysfunction of heart and lungs)
  5. Chronic left ventricular failure (long lasting functional impairment of left ventricle of heart)
  6. Hypoglycaemia (deficiency of glucose in the bloodstream)
  7. Shock (a life-threatening condition with symptoms like low blood pressure, weakness, shallow breathing, cold, clammy skin)
  8. Cardiac failure
  9. Erythema multiforme (a type of hypersensitivity reaction)
  10. Pneumonia

What are the existing conditions these people have? *

  1. Staphylococcal Infection (an infection with staphylococcus bacteria): 4 people, 23.53%
  2. High Blood Pressure: 3 people, 17.65%
  3. Type 2 Diabetes: 3 people, 17.65%
  4. Hypotension (abnormally low blood pressure): 3 people, 17.65%
  5. Back Pain: 2 people, 11.76%
  6. Hypokalemia (low potassium): 2 people, 11.76%
  7. Insomnia (sleeplessness): 2 people, 11.76%
  8. Muscle Spasms (muscle contraction): 2 people, 11.76%
  9. Cardiac Failure: 2 people, 11.76%
  10. Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 2 people, 11.76%

* Approximation only. Some reports may have incomplete information.

Do you take Vancomycin and Nph insulin?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Vancomycin and Nph insulin:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Vancomycin:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Nph insulin:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Vancomycin and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Nph insulin and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

How the study uses the data?

The study uses data from the FDA. It is based on vancomycin and insulin susp isophane beef (the active ingredients of Vancomycin and Nph insulin, respectively), and Vancomycin and Nph insulin (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: